Name
Eurodent Hambaravi OÜ
Registry code
11110298
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
09.02.2005 (19)
Financial year
01.01-31.12
Capital
40 000.00 €
Activity
86231 - Provision of dental treatment
341 080 €
68 133 €
20%
1 977 €
(estimate is approximate)
225 215 €
4
Submitted
No tax arrears
30%
27%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Gerli Eller 26.07.1972 (52) | 50% - 20 000.00 EEK | Board member | Direct ownership | Founder |
| Kirstin Kõnd 08.07.1973 (51) | - | - | - | Founder |
| 2019 15.06.2020 | 2020 06.05.2021 | 2021 15.06.2022 | 2022 10.07.2023 | 2023 21.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 220 325 € | 243 686 € | 219 584 € | 306 178 € | 341 080 € |
| Net profit (loss) for the period | 6 887 € | 38 166 € | 6 950 € | 32 298 € | 68 133 € |
| Profit Margin | 3% | 16% | 3% | 11% | 20% |
| Current Assets | 27 839 € | 44 244 € | 60 594 € | 88 992 € | 154 526 € |
| Fixed Assets | 113 142 € | 134 090 € | 133 959 € | 113 707 € | 93 454 € |
| Total Assets | 140 981 € | 178 334 € | 194 553 € | 202 699 € | 247 980 € |
| Current Liabilities | 61 313 € | 60 500 € | 69 769 € | 45 617 € | 22 765 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 79 668 € | 117 834 € | 124 784 € | 157 082 € | 225 215 € |
| Employees | 3 | 3 | 3 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 14 552.85 € | 15 046.83 € | 4 |
| 2023 Q4 | - | 11 700.46 € | 12 127.38 € | 4 |
| 2023 Q3 | - | 13 358.53 € | 13 859.7 € | 4 |
| 2023 Q2 | - | 13 024.57 € | 13 448.94 € | 5 |
| 2023 Q1 | - | 12 447.53 € | 12 815.74 € | 5 |
| 2022 Q4 | - | 12 852.44 € | 13 295.69 € | 5 |
| 2022 Q3 | - | 11 576.84 € | 11 973.83 € | 5 |
| 2022 Q2 | - | 9 578 € | 9 915.79 € | 5 |
| 2022 Q1 | - | 8 419.74 € | 8 761.14 € | 4 |
| 2021 Q4 | - | 8 124.82 € | 8 518.16 € | 3 |
| 2021 Q3 | - | 8 220.45 € | 8 605.01 € | 4 |
| 2021 Q2 | - | 7 808.24 € | 8 174.93 € | 4 |
| 2021 Q1 | - | 8 017.54 € | 8 401.85 € | 4 |
| 2020 Q4 | - | 8 528.35 € | 8 952.86 € | 4 |
| 2020 Q3 | - | 7 798.43 € | 8 150.84 € | 4 |
| 2020 Q2 | - | 4 985.46 € | 5 131.86 € | 4 |
| 2020 Q1 | - | 7 443.07 € | 7 785.04 € | 3 |
